Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:58
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 106 条
[1]   Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment [J].
Abraham, Deepak T. ;
Low, Tsu-Hui ;
Messina, Marinella ;
Jackson, Nicole ;
Gill, Anthony ;
Chou, Angela S. ;
Delbridge, Leigh ;
Learoyd, Diana ;
Robinson, Bruce G. ;
Sidhu, Stan ;
Sywak, Mark .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (01) :219-225
[2]  
[Anonymous], 2006, BMC MED RES METHODOL, DOI DOI 10.1186/1471-2288-6-50
[3]   Identification of Shc docking site on Ret tyrosine kinase [J].
Arighi, E ;
Alberti, L ;
Torriti, F ;
Ghizzoni, S ;
Rizzetti, MG ;
Pelicci, G ;
Pasini, B ;
Bongarzone, I ;
Piutti, C ;
Pierotti, MA ;
Borrello, MG .
ONCOGENE, 1997, 14 (07) :773-782
[4]   Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma [J].
Barbieri, R. B. ;
Bufalo, N. E. ;
Secolin, R. ;
Silva, A. C. N. ;
Assumpcao, L. V. M. ;
Maciel, R. M. B. ;
Cerutti, J. M. ;
Ward, L. S. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (02) :241-245
[5]   A RET double mutation in the germline of a kindred with FMTC [J].
Bartsch, DK ;
Hasse, C ;
Schug, C ;
Barth, P ;
Rothmund, M ;
Höppner, W .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (02) :128-132
[6]   Polymorphisms in Exon 13 and intron 14 of the RET protooncogene:: Genetic modifiers of medullary thyroid carcinoma? [J].
Baumgartner-Parzer, SM ;
Lang, R ;
Wagner, L ;
Heinze, G ;
Niederle, B ;
Kaserer, K ;
Waldhäusl, W ;
Vierhapper, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6232-6236
[7]   Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population [J].
Berard, I ;
Kraimps, JL ;
Savagner, F ;
Murat, A ;
Renaudin, K ;
Nicolli-Sire, P ;
Bertrand, G ;
Moisan, JP ;
Bezieau, S .
CLINICAL GENETICS, 2004, 65 (02) :150-152
[8]  
Bergholm U, 1997, CANCER-AM CANCER SOC, V79, P132, DOI 10.1002/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO
[9]  
2-5
[10]   A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A [J].
Berndt, I ;
Reuter, M ;
Saller, B ;
Frank-Raue, K ;
Groth, P ;
Grussendorf, M ;
Raue, F ;
Ritter, MM ;
Höppner, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :770-774